Former Senior Vice President, Chief Science Officer and Head of Research and Non-Clinical Development · CytomX Therapeutics, Inc. (CTMX)

W. Michael Kavanaugh

A named executive officer of CytomX Therapeutics in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,639,948

Salary $423,416Stock awards $0

FY2019: $1,476,997

4th of 6 named executive officers at CytomX Therapeutics by FY2020 total.

6 named officers on file for CytomX Therapeutics, FY2020

W. Michael Kavanaugh’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • CTMX’s disclosed peer group of 21 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how CytomX Therapeutics’s whole pay program stands against its peers

  • CytomX Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CTMX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2021 (DEF 14A).

Free

Get W. Michael Kavanaugh’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

W. Michael Kavanaugh compensation by year

CytomX Therapeutics Summary Compensation Table · all 5 fiscal years held
In US dollars, as CytomX Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$395,117$410,921$427,357$444,452$423,416
Bonus$0$0$0$0$0
Stock awards$0$0$0$0$0
Option awards$786,968$884,472$1,128,570$858,654$506,212
Non-equity incentive$193,607$201,351$213,679$168,892$0
Pension and deferred compensation$0$0$0$0$0
All other$6,564$3,000$5,000$5,000$710,320
Total$1,382,256$1,499,744$1,774,606$1,476,997$1,639,948

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CytomX Therapeutics, Inc. DEF 14A filed April 28, 2021, accession 0001140361-21-014772, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CytomX Therapeutics, Inc. filed document, accession 0001140361-21-014772. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2021.

$1.4M
$1.5M
$1.8M
$1.5M
$1.6M
FY16
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option12,000—$7.90

Per the Outstanding Equity Awards at Fiscal Year-End table in CytomX Therapeutics, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

CytomX Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
D. Sean A. McCarthyChief Executive Officer and Chairman of the Board of Directors$2,849,850
Carlos CampoySenior Vice President, Chief Financial Officer$1,741,639
Alison HannahSenior Vice President and Chief Medical Officer$1,677,988
W. Michael Kavanaugh · this pageFormer Senior Vice President, Chief Science Officer and Head of Research and Non-Clinical Development$1,639,948
Lloyd RowlandSenior Vice President, General Counsel, Chief Compliance Officer and Secretary$953,393
Amy PetersonExecutive Vice President, Chief Development Officer$899,442

The full CytomX Therapeutics compensation record

free company brief

This page is one person within CytomX Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the CytomX Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CytomX Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

W. Michael Kavanaugh's compensation dossier · One-time report. No refunds.